A

half dozen U.S. senators want the U.S. Army to hold a public hearing to explore the controversy over the pricing of a Zika virus vaccine that Sanofi is developing with taxpayer dollars.

In a letter sent on Monday to Acting U.S. Secretary of the Army Robert Speer, the lawmakers expressed concerns that a vaccine would not be “accessible and affordable” for many Americans, since the company may win an exclusive license to develop the technology and have “monopolistic” rights through 2036.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Interesting phrase. The ‘reasonable pricing’ was removed – “over concerns that such clauses would be seen by industry as a “restraint” on new product development.” One could wonder how such a concern surfaced – or who surfaced it?

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.